Celcuity (CELC) Receivables - Other (2019 - 2022)

Celcuity (CELC) reported Receivables - Other of $95300.0 for Q2 2022, down 49.84% on a YoY basis from $190000.0 in Q2 2021, and down 50.63% quarter-over-quarter from $193034.0 in Q1 2022.

Celcuity (CELC) Receivables - Other (2019 - 2022) Analysis & Trends

Celcuity has reported Receivables - Other for 4 years, with the latest figure at $95300.0 in Q2 2022.

  • For the quarter ending Q2 2022, Receivables - Other fell 49.84% year-over-year to $95300.0; the trailing twelve-month figure through Jun 2022 stood at $95300.0 (down 49.84% YoY), and the FY2021 full-year result was $298764.0, up 57.24% from the prior year.
  • Receivables - Other for Q2 2022 stood at $95300.0, down from $193034.0 in the prior quarter.
  • The five-year high for Receivables - Other was $356309.0 in Q3 2021, with the low at $95300.0 in Q2 2022.
  • Historically, Receivables - Other has averaged $206673.4 across 4 years, with a median of $190000.0 in 2019.
  • Annual changes were most pronounced in 2021 — Receivables - Other jumped 87.53% — and 2022, when it tumbled 49.84%.
  • Celcuity's Receivables - Other stood at $190000.0 in 2019, then changed by 0.0% to $190000.0 in 2020, then surged by 57.24% to $298764.0 in 2021, then tumbled by 68.1% to $95300.0 in 2022.
  • The last three Receivables - Other figures came in at $95300.0 (Q2 2022), $193034.0 (Q1 2022), and $298764.0 (Q4 2021), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 762,369.55 Bn 762,369.51 Bn -
2 Belite Bio 55,096.00 Bn 55,096.00 Bn -
3 Quantum Biopharma 17,755.80 Bn 17,755.79 Bn -
4 Legend Biotech 3,486.00 Bn 3,485.71 Bn 242.10 Mn
5 Akari Therapeutics 1,737.42 Bn 1,737.41 Bn -
6 Evaxion A 1,551.28 Bn 1,551.26 Bn -
7 Psyence Biomedical 227.32 Bn 227.31 Bn -
8 Vertex Pharmaceuticals 110.84 Bn 103.59 Bn 2.59 Bn
9 Abivax 91.71 Bn 91.71 Bn -
10 Celcuity 4.14 Bn 3.42 Bn -

Historic Data

Download Data
DateValue
Jun 30, 2022 95,300.00
Jun 30, 2022 95,300.00
Mar 31, 2022 193,034.00
Mar 31, 2022 193,034.00
Dec 31, 2021 298,764.00
Dec 31, 2021 298,764.00
Sep 30, 2021 356,309.00
Sep 30, 2021 356,309.00
Jun 30, 2021 190,000.00
Jun 30, 2021 190,000.00
Mar 31, 2021 190,000.00
Mar 31, 2021 190,000.00
Dec 31, 2020 190,000.00
Dec 31, 2020 190,000.00
Sep 30, 2020 190,000.00
Sep 30, 2020 190,000.00
Jun 30, 2020 190,000.00
Jun 30, 2020 190,000.00
Mar 31, 2020 190,000.00
Mar 31, 2020 190,000.00